These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 29998919)

  • 1. Serum 1,25-Dihydroxyvitamin D Level Is Inappropriate for Use in Prospective Studies of Cancer Incidence.
    Grant WB
    Circ J; 2018 Jul; 82(8):2215. PubMed ID: 29998919
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum 1,25-Dihydroxyvitamin D Level Is Inappropriate for Use in Prospective Studies of Cancer Incidence　- Reply.
    Umehara K; Mukai N; Kitazono T; Hoka S; Kiyohara Y; Ninomiya T
    Circ J; 2018 Jul; 82(8):2216. PubMed ID: 29998920
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Prospective study of vitamin D and cancer mortality in the United States.
    Garland CF; Gorham ED; Baggerly CA; Garland FC
    J Natl Cancer Inst; 2008 Jun; 100(11):826-7. PubMed ID: 18505971
    [No Abstract]   [Full Text] [Related]  

  • 4. Stability of 1,25-dihydroxyvitamin D(2) and 1,25-dihydroxyvitamin D(3) in human serum.
    El-Khoury JM; Wang S
    Clin Biochem; 2012 Jun; 45(9):707-8. PubMed ID: 22465273
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective population-based study of the association between serum 25-hydroxyvitamin-D levels and the incidence of specific types of cancer.
    Skaaby T; Husemoen LL; Thuesen BH; Pisinger C; Jørgensen T; Roswall N; Larsen SC; Linneberg A
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1220-9. PubMed ID: 24789846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.
    Tworoger SS; Lee IM; Buring JE; Rosner B; Hollis BW; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):783-8. PubMed ID: 17416771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum 1,25-Dihydroxyvitamin D as a Biomarker of the Absence of Hypercalciuria in Postsurgical Hypoparathyroidism.
    García-Pascual L; Barahona MJ; Perea V; Simó R
    J Clin Endocrinol Metab; 2017 Jan; 102(1):259-266. PubMed ID: 27813709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma 1,25-Dihydroxyvitamin D and the Risk of Developing Hypertension: The Prevention of Renal and Vascular End-Stage Disease Study.
    van Ballegooijen AJ; Gansevoort RT; Lambers-Heerspink HJ; de Zeeuw D; Visser M; Brouwer IA; Kema IP; de Borst MH; Bakker SJ; Joosten MM
    Hypertension; 2015 Sep; 66(3):563-70. PubMed ID: 26195480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of hypercalcemia Indications for 1,25-dihydroxyvitamin D prescription.
    Malandain D; Roussey G; Leloupp AG; Graveline N; Masson D; Bach-Ngohou K
    Ann Biol Clin (Paris); 2015; 73(5):573-80. PubMed ID: 26489816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of beta-carotene supplementation on serum vitamin D metabolite concentrations.
    Freedman DM; Tangrea JA; Virtamo J; Albanes D
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1115-6. PubMed ID: 10613346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of serum 25-hydroxyvitamin D level with incidence of lung cancer and histologic types in Norwegian adults: a case-cohort analysis of the HUNT study.
    Sun YQ; Langhammer A; Wu C; Skorpen F; Chen Y; Nilsen TIL; Romundstad PR; Mai XM
    Eur J Epidemiol; 2018 Jan; 33(1):67-77. PubMed ID: 29080012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D status and skin cancer risk independent of time outdoors: 11-year prospective study in an Australian community.
    van der Pols JC; Russell A; Bauer U; Neale RE; Kimlin MG; Green AC
    J Invest Dermatol; 2013 Mar; 133(3):637-641. PubMed ID: 23076499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers.
    Grant WB
    J Photochem Photobiol B; 2010 Nov; 101(2):130-6. PubMed ID: 20570169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of serum vitamin D and cancer mortality in the United States.
    Freedman DM; Looker AC; Chang SC; Graubard BI
    J Natl Cancer Inst; 2007 Nov; 99(21):1594-602. PubMed ID: 17971526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between frailty and serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations in older Australian men: the Concord Health and Ageing in Men Project.
    Hirani V; Naganathan V; Cumming RG; Blyth F; Le Couteur DG; Handelsman DJ; Waite LM; Seibel MJ
    J Gerontol A Biol Sci Med Sci; 2013 Sep; 68(9):1112-21. PubMed ID: 23657973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25 Dihydroxyvitamin D and cancer.
    Palmieri GM
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3516-7. PubMed ID: 9329398
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitamin D and breast cancer incidence and outcome.
    Chlebowski RT
    Anticancer Agents Med Chem; 2013 Jan; 13(1):98-106. PubMed ID: 23094925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer.
    Jacobs ET; Giuliano AR; Martínez ME; Hollis BW; Reid ME; Marshall JR
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):533-7. PubMed ID: 15225833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of serum vitamin D levels in Chinese infertile men.
    Zhu CL; Xu QF; Li SX; Wei YC; Zhu GC; Yang C; Shi YC
    Andrologia; 2016 Dec; 48(10):1261-1266. PubMed ID: 26992658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.
    Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M
    Br J Nutr; 2016 Jan; 115(2):305-14. PubMed ID: 26568368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.